Aqueous and alcoholic extracts of Triphala and their active compounds chebulagic acid and chebulinic acid prevented epithelial to mesenchymal transition in retinal pigment epithelial cells, by inhibiting SMAD-3 phosphorylation

PloS One
Shanmuganathan SivasankarNarayanasamy Angayarkanni

Abstract

Epithelial to Mesenchymal Transition (EMT) of the retinal pigment epithelium is involved in the pathogenesis of proliferative vitreoretinopathy (PVR) that often leads to retinal detachment. In this study, Triphala, an ayurvedic formulation and two of its active ingredients, namely chebulagic acid and chebulinic acid were evaluated for anti-EMT properties based on in vitro experiments in human retinal pigment epithelial cell line (ARPE-19) under TGFβ1 induced conditions. ARPE-19 cells were treated with TGFβ1 alone or co-treated with various concentrations of aqueous extract (AqE) (30-300 μg/ml); alcoholic extract (AlE) (50-500 μg/ml) of triphala and the active principles chebulagic acid (CA) and chebulinic acid (CI) (CA,CI: 50-200 μM). The expression of EMT markers namely MMP-2, αSMA, vimentin and the tight junction protein ZO-1 were evaluated by qPCR, western blot and immunofluorescence. The functional implications of EMT, namely migration and proliferation of cells were assessed by proliferation assay, scratch assay and transwell migration assay. AqE, AlE, CA and CI reduced the expression and activity of MMP-2 at an ED50 value of 100 μg/ml, 50 μg/ml, 100 μM and 100 μM, respectively. At these concentrations, a significant down-...Continue Reading

References

Oct 1, 1995·The British Journal of Ophthalmology·D G Charteris
Jan 1, 1993·American Journal of Ophthalmology·S J Ryan
Feb 1, 1997·Archives of Ophthalmology·P A Campochiaro
Oct 6, 1997·The EMBO Journal·A NakaoP ten Dijke
Apr 16, 1998·Progress in Retinal and Eye Research·H NagasakiM Mochizuki
Jul 25, 1998·Klinische Monatsblätter für Augenheilkunde·C J PournarasG Gabbiani
Aug 26, 1998·Survey of Ophthalmology·J C Pastor
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Mar 22, 2002·Progress in Retinal and Eye Research·J Carlos PastorFrancisco Martín
Dec 18, 2003·The Journal of Clinical Investigation·Raghu Kalluri, Eric G Neilson
Dec 31, 2003·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Tuan D Duong, Carol A Erickson
Mar 17, 2004·Free Radical Biology & Medicine·Robert J WilliamsCatherine Rice-Evans
May 25, 2004·International Journal of Experimental Pathology·Kathleen C Flanders
Jul 27, 2004·Laboratory Investigation; a Journal of Technical Methods and Pathology·Shizuya SaikaAnita B Roberts
Feb 16, 2005·Laboratory Investigation; a Journal of Technical Methods and Pathology·Stephen J GiebelArup Das
Feb 17, 2005·The Journal of Biological Chemistry·Svetlana ErmakovaZigang Dong
Apr 29, 2005·Journal of Periodontology·Sajith AbrahamN D Jayakumar
Aug 1, 2006·Investigative Ophthalmology & Visual Science·Janice M Burke, Jeehee Hong
Jul 31, 2007·The Journal of Surgical Research·Muthusamy Senthil KumarPraveen Kumar Sehgal
Aug 29, 2007·Investigative Ophthalmology & Visual Science·Helena LeeRosemary Kane
Sep 1, 2007·Journal of Biosciences·Venil N SumantranUlhas V Wagh
Apr 9, 2008·Endocrine, Metabolic & Immune Disorders Drug Targets·Shizuya SaikaKazuo Ikeda
Jun 19, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Deepti NavaratnaArup Das
Jun 21, 2008·Investigative Ophthalmology & Visual Science·Karunakaran CoralSubramanian Krishnakumar
Sep 9, 2008·Progress in Retinal and Eye Research·Janice M Burke
Dec 6, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Andrea S RothmeierStefan Zahler
Jan 21, 2009·Cell Research·Jian XuRik Derynck
Apr 9, 2009·Biochemical and Biophysical Research Communications·D Bharat Reddy, Pallu Reddanna
Jun 3, 2009·The Journal of Clinical Investigation·Raghu Kalluri
Jun 3, 2009·The Journal of Clinical Investigation·Michael Zeisberg, Eric G Neilson
Feb 24, 2010·The British Journal of Nutrition·Jung-Mi YunSridevi Devaraj
Mar 30, 2011·Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology·Brenda Thornton, Chhandak Basu
Mar 7, 2012·Laboratory Investigation; a Journal of Technical Methods and Pathology·Hung-Chi ChenScheffer C G Tseng

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
PCR
Assay

Software Mentioned

win
NIH image - J
CAMAG REPROSTAR
CATS

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.